Yunfei Yuan
- Cancer Research top 0.2%
- MicroRNA in disease regulation 26
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 69
- Molecular Biology top 1%
- RNA modifications and cancer 26
- Cancer-related gene regulation 19
- Epigenetics and DNA Methylation 18
- Oncology top 1%
- Immunology top 5%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 27
-
- Liver Disease Diagnosis and Treatment 25
-
- Cancer Mechanisms and Therapy 20
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (2 papers)Nature Communications (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Yunfei Yuan
184 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 3.7k
- Hepatology 1.6k
- Molecular Biology 4.8k
- Oncology 1.7k
- Immunology 819
Countries citing papers authored by Yunfei Yuan
This map shows the geographic impact of Yunfei Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunfei Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunfei Yuan more than expected).
Fields of papers citing papers by Yunfei Yuan
This network shows the impact of papers produced by Yunfei Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunfei Yuan. The network helps show where Yunfei Yuan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yunfei Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 19 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 13 | |
| 8 | TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching studybreakdown → | 2023 | 71 |
| 9 | 2021 | 4 | |
| 10 | 2021 | 10 | |
| 11 | 2020 | 52 | |
| 12 | Identification of High-Frequency Methylation Sites in RNF180 Promoter Region Affecting Expression and Their Relationship with Prognosis of Gastric Cancer | 2020 | 1 |
| 13 | 2018 | 34 | |
| 14 | 2017 | 42 | |
| 15 | 2014 | 37 | |
| 16 | 2013 | 186 | |
| 17 | 2013 | 88 | |
| 18 | 2012 | 15 | |
| 19 | 2011 | 4 | |
| 20 | MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicitybreakdown → | 2009 | 533 |
About Yunfei Yuan
Yunfei Yuan is a scholar working on Hepatology, Cancer Research and Oncology, having authored 187 papers that have together received 8.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (69 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers), RNA modifications and cancer (26 papers), MicroRNA in disease regulation (26 papers), Liver Disease Diagnosis and Treatment (25 papers), Cancer Mechanisms and Therapy (20 papers), Cancer-related gene regulation (19 papers) and Epigenetics and DNA Methylation (18 papers). The work is most often cited by research in Cancer Research (3.7k citations), Hepatology (1.6k citations) and Molecular Biology (4.8k citations). Yunfei Yuan has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Shi‐Mei Zhuang, Binkui Li, Xin‐Yuan Guan, Jun Huang, Xu Teng, Hang Su, Jian‐Hong Fang, Jiliang Qiu, Jian‐Rong Yang and Leilei Chen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.